Gender dimorphisms in progenitor and stem cell function in cardiovascular disease

Journal of Cardiovascular Translational Research

Volumn 3, Issue 2, 2010, Pages 103-113

  Herrmann, Jeremy L ^a   Abarbanell, Aaron M ^a   Weil, Brent R ^a   Manukyan, Mariuxi C ^a   Poynter, Jeffrey A ^a   Wang, Yue ^a   Coffey, Arthur C ^a   Meldrum, Daniel R ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Indiana University School of Medicine ^*  (United States)

Author keywords

Cardiovascular disease; Gender differences; Progenitor cells; Sex steroids; Stem cell therapy

Indexed keywords

ESTRADIOL; TESTOSTERONE; SEX HORMONE;

CARDIOVASCULAR DISEASE; CELL FUNCTION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FEMALE; HEART PROTECTION; HUMAN; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; STEM CELL; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; HEART MUSCLE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; SEXUAL DEVELOPMENT; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; REGENERATION; SEX CHARACTERISTICS; SEX FACTORS; TESTOSTERONE; TREATMENT OUTCOME; MESENCHYMAL STROMAL CELLS;

EID: 77953610377     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9149-y     Document Type: Review

References (124)

1. Kher, A., Meldrum, K. K., Wang, M., Tsai, B. M., Pitcher, J. M., & Meldrum, D. R. (2005). Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. Cardiovascular Research, 67, 594-603.
2. Choudhry, M. A., Schwacha, M. G., Hubbard, W. J., Kerby, J. D., Rue, L. W., Bland, K. I., et al. (2005). Gender differences in acute response to trauma-hemorrhage. Shock, 24(Suppl 1), 101-106.
3. Choudhry, M. A., Bland, K. I., & Chaudry, I. H. (2006). Gender and susceptibility to sepsis following trauma. Endocr Metab Immune Disord Drug Targets, 6, 127-135.
4. Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E., et al. (1991). Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. New England Journal of Medicine, 325, 756-762.
5. Kher, A., Wang, M., Tsai, B. M., Pitcher, J. M., Greenbaum, E. S., Nagy, R. D., et al. (2005). Sex differences in the myocardial inflammatory response to acute injury. Shock, 23, 1-10.
6. Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., et al. (1992). Hormone therapy to prevent disease and prolong life in postmenopausal women. Annals of Internal Medicine, 117, 1016-1037.
7. Urbich, C. & Dimmeler, S. (2004). Endothelial progenitor cells: Characterization and role in vascular biology. Circulation Research, 95, 343-353.
8. Crisostomo, P. R., Wang, M., Markel, T. A., Lahm, T., Abarbanell, A. M., Herrmann, J. L., et al. (2007). Stem cell mechanisms and paracrine effects: Potential in cardiac surgery. Shock, 28, 375-383.
9. Crisostomo, P. R., Abarbanell, A. M., Wang, M., Lahm, T., Wang, Y., & Meldrum, D. R. (2008). Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. American Journal of Physiology. Heart and Circulatory Physiology, 295, H1726-H1735.
10. Farhat, M. Y., Lavigne, M. C., & Ramwell, P. W. (1996). The vascular protective effects of estrogen. FASEB Journal, 10, 615-624.
11. Mosselman, S., Polman, J., & Dijkema, R. (1996). ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Letters, 392, 49-53.
12. Villablanca, A. C., Tenwolde, A., Lee, M., Huck, M., Mumenthaler, S., & Rutledge, J. C. (2009). 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice. J Cardiovasc Transl Res, 2, 289-299.
13. Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., et al. (2001). Mechanisms of estrogen action. Physiological Reviews, 81, 1535-1565.
14. Liu, H., Liu, K., & Bodenner, D. L. (2005). Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation. Cytokine, 31, 251-257.
15. Hamada, H., Kim, M. K., Iwakura, A., Ii, M., Thorne, T., Qin, G., et al. (2006). Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation, 114, 2261-2270.
16. Shao, R., Egecioglu, E., Weijdegard, B., Kopchick, J. J., Fernandez-Rodriguez, J., Andersson, N., et al. (2007). Dynamic regulation of estrogen receptor-alpha isoform expression in the mouse fallopian tube: Mechanistic insight into estrogendependent production and secretion of insulin-like growth factors. Am J Physiol Endocrinol Metab, 293, E1430-E1442.
17. Matthews, J., Almlof, T., Kietz, S., Leers, J., & Gustafsson, J. A. (2005). Estrogen receptor-alpha regulates SOCS-3 expression in human breast cancer cells. Biochemical and Biophysical Research Communications, 335, 168-174.
18. Roggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G., et al. (2001). Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proceedings of the National Academy of Sciences of the United States of America, 98, 13960-13965.
19. Leung, S. W., Teoh, H., Keung, W., & Man, R. Y. (2007). Nongenomic vascular actions of female sex hormones: Physiological implications and signalling pathways. Clinical and Experimental Pharmacology and Physiology, 34, 822-826.
20. Kim, K. H., Moriarty, K., & Bender, J. R. (2008). Vascular cell signaling by membrane estrogen receptors. Steroids, 73, 864-869.
21. Krasinski, K., Spyridopoulos, I., Asahara, T., van der Zee, R., Isner, J. M., & Losordo, D. W. (1997). Estradiol accelerates functional endothelial recovery after arterial injury. Circulation, 95, 1768-1772.
22. Brouchet, L., Krust, A., Dupont, S., Chambon, P., Bayard, F., & Arnal, J. F. (2001). Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation, 103, 423-428.
23. Toutain, C. E., Filipe, C., Billon, A., Fontaine, C., Brouchet, L., Guery, J. C., et al. (2009). Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization. Arteriosclerosis, Thrombosis and Vascular Biology, 29, 1543-1550.
24. Makela, S., Savolainen, H., Aavik, E., Myllarniemi, M., Strauss, L., Taskinen, E., et al. (1999). Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proceedings of the National Academy of Sciences of the United States of America, 96, 7077-7082.
25. Wang, M., Wang, Y., Weil, B., Abarbanell, A., Herrmann, J., Tan, J., et al. (2009). Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 296, R972-R978.
26. Iafrati, M. D., Karas, R. H., Aronovitz, M., Kim, S., Sullivan, T. R., Jr., Lubahn, D. B., et al. (1997). Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nature Medicine, 3, 545-548.
27. Karas, R. H., Hodgin, J. B., Kwoun, M., Krege, J. H., Aronovitz, M., Mackey, W., et al. (1999). Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proceedings of the National Academy of Sciences of the United States of America, 96, 15133-15136.
28. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., et al. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA, 280, 605-613.
29. Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., et al. (2002). Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA, 288, 49-57.
30. Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333.
31. Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A., Black, H., et al. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA, 291, 1701-1712.
32. Wang, M., Wang, Y., Abarbanell, A., Tan, J., Weil, B., Herrmann, J., et al. (2009). Both endogenous and exogenous testosterone decrease myocardial STAT3 activation and SOCS3 expression after acute ischemia and reperfusion. Surgery, 146, 138-144.
33. Alexandersen, P., Haarbo, J., Byrjalsen, I., Lawaetz, H., & Christiansen, C. (1999). Natural androgens inhibit male atherosclerosis: A study in castrated, cholesterol-fed rabbits. Circulation Research, 84, 813-819.
34. Dockery, F., Bulpitt, C. J., Donaldson, M., Fernandez, S., & Rajkumar, C. (2003). The relationship between androgens and arterial stiffness in older men. Journal of the American Geriatrics Society, 51, 1627-1632.
35. Hougaku, H., Fleg, J. L., Najjar, S. S., Lakatta, E. G., Harman, S. M., Blackman, M. R., et al. (2006). Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab, 290, E234-E242.
36. Kang, S. M., Jang, Y., Kim, J. Y., Chung, N., Cho, S. Y., Chae, J. S., et al. (2002). Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease. American Journal of Cardiology, 89, 862-864.
37. Rosano, G. M., Leonardo, F., Pagnotta, P., Pelliccia, F., Panina, G., Cerquetani, E., et al. (1999). Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation, 99, 1666-1670.
38. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275, 964-967.
39. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine, 7, 430-436.
40. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., et al. (1999). Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine, 5, 434-438.
41. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine, 10, 858-864.
42. Elmadbouh, I., Haider, H., Jiang, S., Idris, N. M., Lu, G., & Ashraf, M. (2007). Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. Journal of Molecular and Cellular Cardiology, 42, 792-803.
43. Li, B., Sharpe, E. E., Maupin, A. B., Teleron, A. A., Pyle, A. L., Carmeliet, P., et al. (2006). VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB Journal, 20, 1495-1497.
44. Aicher, A., Heeschen, C., Mildner-Rihm, C., Urbich, C., Ihling, C., Technau-Ihling, K., et al. (2003). Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nature Medicine, 9, 1370-1376.
45. Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Honma, T., Katoh, A., et al. (2001). Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 103, 2776-2779.
46. Gill, M., Dias, S., Hattori, K., Rivera, M. L., Hicklin, D., Witte, L., et al. (2001). Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circulation Research, 88, 167-174.
47. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., et al. (1999). VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO Journal, 18, 3964-3972.
48. Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W. M., Silver, M., Kearney, M., et al. (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Sciences of the United States of America, 97, 3422-3427.
49. Kawamoto, A., Gwon, H. C., Iwaguro, H., Yamaguchi, J. I., Uchida, S., Masuda, H., et al. (2001). Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation, 103, 634-637.
50. Jujo, K., Ii, M., & Losordo, D. W. (2008). Endothelial progenitor cells in neovascularization of infarcted myocardium. Journal of Molecular and Cellular Cardiology, 45, 530-544.
51. Kang, H. J., Kim, H. S., Zhang, S. Y., Park, K. W., Cho, H. J., Koo, B. K., et al. (2004). Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet, 363, 751-756.
52. Hill, J. M., Zalos, G., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., et al. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New England Journal of Medicine, 348, 593-600.
53. Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., et al. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. New England Journal of Medicine, 353, 999-1007.
54. Scheubel, R. J., Zorn, H., Silber, R. E., Kuss, O., Morawietz, H., Holtz, J., et al. (2003). Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. Journal of the American College of Cardiology, 42, 2073-2080.
55. Tepper, O. M., Galiano, R. D., Capla, J. M., Kalka, C., Gagne, P. J., Jacobowitz, G. R., et al. (2002). Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation, 106, 2781-2786.
56. Loomans, C. J., de Koning, E. J., Staal, F. J., Rookmaaker, M. B., Verseyden, C., de Boer, H. C., et al. (2004). Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes, 53, 195-199.
57. Simper, D., Wang, S., Deb, A., Holmes, D., McGregor, C., Frantz, R., et al. (2003). Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation, 108, 143-149.
58. George, J., Goldstein, E., Abashidze, S., Deutsch, V., Shmilovich, H., Finkelstein, A., et al. (2004). Circulating endothelial progenitor cells in patients with unstable angina: Association with systemic inflammation. European Heart Journal, 25, 1003-1008.
59. Choi, J. H., Kim, K. L., Huh, W., Kim, B., Byun, J., Suh, W., et al. (2004). Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1246-1252.
60. Imanishi, T., Moriwaki, C., Hano, T., & Nishio, I. (2005). Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. Journal of Hypertension, 23, 1831-1837.
61. Ghani, U., Shuaib, A., Salam, A., Nasir, A., Shuaib, U., Jeerakathil, T., et al. (2005). Endothelial progenitor cells during cerebrovascular disease. Stroke, 36, 151-153.
62. Iwakura, A., Luedemann, C., Shastry, S., Hanley, A., Kearney, M., Aikawa, R., et al. (2003). Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrowderived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation, 108, 3115-3121.
63. Strehlow, K., Werner, N., Berweiler, J., Link, A., Dirnagl, U., Priller, J., et al. (2003). Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation, 107, 3059-3065.
64. Zhao, X., Huang, L., Yin, Y., Fang, Y., Zhao, J., & Chen, J. (2008). Estrogen induces endothelial progenitor cells proliferation and migration by estrogen receptors and PI3K-dependent pathways. Microvascular Research, 75, 45-52.
65. Iwakura, A., Shastry, S., Luedemann, C., Hamada, H., Kawamoto, A., Kishore, R., et al. (2006). Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation, 113, 1605-1614.
66. Fontaine, V., Filipe, C., Werner, N., Gourdy, P., Billon, A., Garmy-Susini, B., et al. (2006). Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization. American Journal of Pathology, 169, 1855-1862.
67. Rousseau, A., Ayoubi, F., Deveaux, C., Charbit, B., Delmau, C., Christin-Maitre, S., et al. (2009). Impact of age and gender interaction on circulating endothelial progenitor cells in healthy subjects. Fertility and Sterility (in press).
68. Lemieux, C., Cloutier, I., & Tanguay, J. F. (2009). Menstrual cycle influences endothelial progenitor cell regulation: A link to gender differences in vascular protection? International Journal of Cardiology, 136, 200-210.
69. Fadini, G. P., de Kreutzenberg, S., Albiero, M., Coracina, A., Pagnin, E., Baesso, I., et al. (2008). Gender differences in endothelial progenitor cells and cardiovascular risk profile: The role of female estrogens. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 997-1004.
70. Hoetzer, G. L., MacEneaney, O. J., Irmiger, H. M., Keith, R., Van Guilder, G. P., Stauffer, B. L., et al. (2007). Gender differences in circulating endothelial progenitor cell colonyforming capacity and migratory activity in middle-aged adults. American Journal of Cardiology, 99, 46-48.
71. Foresta, C., Caretta, N., Lana, A., De Toni, L., Biagioli, A., Ferlin, A., et al. (2006). Reduced number of circulating endothelial progenitor cells in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 91, 4599-4602.
72. Foresta, C., Zuccarello, D., De Toni, L., Garolla, A., Caretta, N., & Ferlin, A. (2008). Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway. Clinical Endocrinology (Oxford), 68, 284-289.
73. Fadini, G. P., Albiero, M., Cignarella, A., Bolego, C., Pinna, C., Boscaro, E., et al. (2009). Effects of androgens on endothelial progenitor cells in vitro and in vivo. Clinical Science (London), 117, 355-364.
74. Kim, S. W., Hwang, J. H., Cheon, J. M., Park, N. S., Park, S. E., Park, S. J., et al. (2005). Direct and indirect effects of androgens on survival of hematopoietic progenitor cells in vitro. Journal of Korean Medical Science, 20, 409-416.
75. Garolla, A., D'Inca, R., Checchin, D., Biagioli, A., De Toni, L., Nicoletti, V., et al. (2009). Reduced endothelial progenitor cell number and function in inflammatory bowel disease: A possible link to the pathogenesis. American Journal of Gastroenterology, 104, 2500-2507.
76. Conget, P. A., & Minguell, J. J. (1999). Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. Journal of Cellular Physiology, 181, 67-73.
77. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93-98.
78. Crisostomo, P. R., Markel, T. A., Wang, Y., & Meldrum, D. R. (2008). Surgically relevant aspects of stem cell paracrine effects. Surgery, 143, 577-581.
79. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838-3843.
80. Abdel-Latif, A., Bolli, R., Tleyjeh, I. M., Montori, V. M., Perin, E. C., Hornung, C. A., et al. (2007). Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Archives of Internal Medicine, 167, 989-997.
81. Lipinski, M. J., Biondi-Zoccai, G. G., Abbate, A., Khianey, R., Sheiban, I., Bartunek, J., et al. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. Journal of the American College of Cardiology, 50, 1761-1767.
82. Crisostomo, P. R., Wang, M., Herring, C. M., Morrell, E. D., Seshadri, P., Meldrum, K. K., et al. (2006). Sex dimorphisms in activated mesenchymal stem cell function. Shock, 26, 571-574.
83. Hiasa, K., Egashira, K., Kitamoto, S., Ishibashi, M., Inoue, S., Ni, W., et al. (2004). Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor. Basic Research in Cardiology, 99, 165-172
84. Meldrum, D. R. (1998). Tumor necrosis factor in the heart. American Journal of Physiology, 274, R577-R595.
85. Crisostomo, P. R., Markel, T. A., Wang, M., Lahm, T., Lillemoe, K. D., & Meldrum, D. R. (2007). In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery, 142, 215-221.
86. Erwin, G. S., Crisostomo, P. R., Wang, Y., Wang, M., Markel, T. A., Guzman, M., et al. (2009). Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia. Journal of Surgical Research, 152, 319-324.
87. Wang, M., Tan, J., Coffey, A., Fehrenbacher, J., Weil, B. R., & Meldrum, D. R. (2009). Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1alpha mediates estrogen receptor-alpha-induced mesenchymal stem cell vascular endothelial growth factor production. Journal of Thoracic and Cardiovascular Surgery, 138, 163-171, 171 e161.
88. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., et al. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology, 16, 4604-4613.
89. Wang, M., Zhang, W., Crisostomo, P., Markel, T., Meldrum, K. K., Fu, X. Y., et al. (2007). STAT3 mediates bone marrow mesenchymal stem cell VEGF production. Journal of Molecular and Cellular Cardiology, 42, 1009-1015.
90. Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., et al. (2002). Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene, 21, 2000-2008.
91. Platt, D. H., Bartoli, M., El-Remessy, A. B., Al-Shabrawey, M., Lemtalsi, T., Fulton, D., et al. (2005). Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3. Free Radical Biology and Medicine, 39, 1353-1361.
92. Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., et al. (2005). Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene, 24, 5552-5560.
93. Gao, H., Bryzgalova, G., Hedman, E., Khan, A., Efendic, S., Gustafsson, J. A., et al. (2006). Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: A possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Molecular Endocrinology, 20, 1287-1299.
94. Yun, S. P., Lee, M. Y., Ryu, J. M., Song, C. H., & Han, H. J. (2009). Role of HIF-1alpha and VEGF in human mesenchymal stem cell proliferation by 17beta-estradiol: Involvement of PKC, PI3K/Akt, and MAPKs. American Journal of Physiology. Cell Physiology, 296, C317-C326.
95. Zhou, S., Turgeman, G., Harris, S. E., Leitman, D. C., Komm, B. S., Bodine, P. V., et al. (2003). Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Molecular Endocrinology, 17, 56-66.
96. Wang, M., Tsai, B. M., Crisostomo, P. R., & Meldrum, D. R. (2006). Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia. Circulation, 114, I282-I289.
97. Crisostomo, P. R., Wang, M., Herring, C. M., Markel, T. A., Meldrum, K. K., Lillemoe, K. D., et al. (2007). Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: Role of the 55 kDa TNF receptor (TNFR1). Journal of Molecular and Cellular Cardiology, 42, 142-149.
98. Markel, T. A., Crisostomo, P. R., Wang, M., Wang, Y., Lahm, T., Novotny, N. M., et al. (2008). TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 295, R1124-R1130.
99. DiSilvio, L., Jameson, J., Gamie, Z., Giannoudis, P. V., & Tsiridis, E. (2006). In vitro evaluation of the direct effect of estradiol on human osteoblasts (HOB) and human mesenchymal stem cells (h-MSCs). Injury, 37(Suppl 3), S33-S42.
100. Hong, L., Colpan, A., & Peptan, I. A. (2006). Modulations of 17-beta estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells. Tissue Engineering, 12, 2747-2753.
101. Zhou, S., Zilberman, Y., Wassermann, K., Bain, S. D., Sadovsky, Y., & Gazit, D. (2001). Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. Journal of Cellular Biochemistry. Supplement, Suppl 36, 144-155.
102. Cha, Y., Kwon, S. J., Seol, W., & Park, K. S. (2008). Estrogen receptor-alpha mediates the effects of estradiol on telomerase activity in human mesenchymal stem cells. Molecules and Cells, 26, 454-458.
103. Ray, R., Herring, C. M., Markel, T. A., Crisostomo, P. R., Wang, M., Weil, B., et al. (2008). Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 294, R1498-R1503.
104. Min, J. Y., Yang, Y., Sullivan, M. F., Ke, Q., Converso, K. L., Chen, Y., et al. (2003). Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. Journal of Thoracic and Cardiovascular Surgery, 125, 361-369.
105. Leor, J., Gerecht, S., Cohen, S., Miller, L., Holbova, R., Ziskind, A., et al. (2007). Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart, 93, 1278-1284.
106. Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A., Ware, C. B., Masino, A., et al. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB Journal, 21, 1345-1357.
107. Behfar, A., Zingman, L. V., Hodgson, D. M., Rauzier, J. M., Kane, G. C., Terzic, A., et al. (2002). Stem cell differentiation requires a paracrine pathway in the heart. FASEB Journal, 16, 1558-1566.
108. Behfar, A., Perez-Terzic, C., Faustino, R. S., Arrell, D. K., Hodgson, D. M., Yamada, S., et al. (2007). Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. Journal of Experimental Medicine, 204, 405-420.
109. Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25, 1015-1024.
110. Caspi, O., Huber, I., Kehat, I., Habib, M., Arbel, G., Gepstein, A., et al. (2007). Transplantation of human embryonic stem cellderived cardiomyocytes improves myocardial performance in infarcted rat hearts. Journal of the American College of Cardiology, 50, 1884-1893.
111. Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120, 408-416.
112. Hong, S. H., Nah, H. Y., Lee, Y. J., Lee, J. W., Park, J. H., Kim, S. J., et al. (2004). Expression of estrogen receptor-alpha and -beta, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodies. Molecules and Cells, 18, 320-325.
113. Han, H. J., Heo, J. S., & Lee, Y. J. (2006). Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: Involvement of MAPKs and CDKs as well as protooncogenes. American Journal of Physiology. Cell Physiology, 290, C1067-C1075
114. Chang, C. Y., Hsuuw, Y. D., Huang, F. J., Shyr, C. R., Chang, S. Y., Huang, C. K., et al. (2006). Androgenic and antiandrogenic effects and expression of androgen receptor in mouse embryonic stem cells. Fertility and Sterility, 85(Suppl 1), 1195-1203.
115. Goldman-Johnson, D. R., de Kretser, D. M., & Morrison, J. R. (2008). Evidence that androgens regulate early developmental events, prior to sexual differentiation. Endocrinology, 149, 5-14.
116. Arrell, D. K., Niederlander, N. J., Faustino, R. S., Behfar, A., & Terzic, A. (2008). Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells, 26, 387-400.
117. Nelson, T. J., Faustino, R. S., Chiriac, A., Crespo-Diaz, R., Behfar, A., & Terzic, A. (2008). CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells, 26, 1464-1473.
118. Keaney, J. F., Jr., Shwaery, G. T., Xu, A., Nicolosi, R. J., Loscalzo, J., Foxall, T. L., et al. (1994). 17beta-estradiol preserves endothelial vasodilator function and limits lowdensity lipoprotein oxidation in hypercholesterolemic swine. Circulation, 89, 2251-2259.
119. Moskowitz, M. S., Moskowitz, A. A., Bradford, W. L., Jr., & Wissler, R. W. (1956). Changes in serum lipids and coronary arteries of the rat in response to estrogens. AMA Archives of Pathology, 61, 245-263.
120. Adams, M. R., Kaplan, J. R., Manuck, S. B., Koritnik, D. R., Parks, J. S., Wolfe, M. S., et al. (1990). Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: Lack of an effect of added progesterone. Arteriosclerosis, 10, 1051-1057.
121. Palmer, R. M., Ferrige, A. G., & Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature, 327, 524-526.
122. Bath, P. M., Hassall, D. G., Gladwin, A. M., Palmer, R. M., & Martin, J. F. (1991). Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arteriosclerosis and Thrombosis, 11, 254-260.
123. Radomski, M. W., Palmer, R. M., & Moncada, S. (1987). Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet, 2, 1057-1058.
124. Lahm, T., Patel, K. M., Crisostomo, P. R., Markel, T. A., Wang, M., Herring, C., et al. (2007). Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: The effects of sex and menstrual cycle. Am J Physiol Endocrinol Metab, 293, E865-E871